967 related articles for article (PubMed ID: 8207057)
1. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.
Rando TA; Blau HM
J Cell Biol; 1994 Jun; 125(6):1275-87. PubMed ID: 8207057
[TBL] [Abstract][Full Text] [Related]
2. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers.
Pavlath GK; Rando TA; Blau HM
J Cell Biol; 1994 Dec; 127(6 Pt 2):1923-32. PubMed ID: 7806570
[TBL] [Abstract][Full Text] [Related]
3. The fate of myoblasts following transplantation into mature muscle.
Rando TA; Pavlath GK; Blau HM
Exp Cell Res; 1995 Oct; 220(2):383-9. PubMed ID: 7556447
[TBL] [Abstract][Full Text] [Related]
4. Limitations of nls beta-galactosidase as a marker for studying myogenic lineage or the efficacy of myoblast transfer.
Yang J; Ontell MP; Kelly R; Watkins SC; Ontell M
Anat Rec; 1997 May; 248(1):40-50. PubMed ID: 9143666
[TBL] [Abstract][Full Text] [Related]
5. The influence of muscle fiber type in myoblast-mediated gene transfer to skeletal muscles.
Petersen ZQ; Huard J
Cell Transplant; 2000; 9(4):503-17. PubMed ID: 11038067
[TBL] [Abstract][Full Text] [Related]
6. Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells.
Yao SN; Kurachi K
J Cell Sci; 1993 Aug; 105 ( Pt 4)():957-63. PubMed ID: 8227217
[TBL] [Abstract][Full Text] [Related]
7. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
Kinoshita I; Huard J; Tremblay JP
Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
[TBL] [Abstract][Full Text] [Related]
8. Myoblast transplantation in non-dystrophic dog.
Ito H; Vilquin JT; Skuk D; Roy B; Goulet M; Lille S; Dugré FJ; Asselin I; Roy R; Fardeau M; Tremblay JP
Neuromuscul Disord; 1998 Apr; 8(2):95-110. PubMed ID: 9608563
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice.
Kinoshita I; Vilquin JT; Tremblay JP
Acta Neuropathol; 1996; 91(5):489-93. PubMed ID: 8740229
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer into skeletal muscles by isogenic myoblasts.
Huard J; Acsadi G; Jani A; Massie B; Karpati G
Hum Gene Ther; 1994 Aug; 5(8):949-58. PubMed ID: 7948144
[TBL] [Abstract][Full Text] [Related]
11. Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA.
Hamamori Y; Samal B; Tian J; Kedes L
Hum Gene Ther; 1994 Nov; 5(11):1349-56. PubMed ID: 7893806
[TBL] [Abstract][Full Text] [Related]
12. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
13. Absence of MyoD increases donor myoblast migration into host muscle.
Smythe GM; Grounds MD
Exp Cell Res; 2001 Jul; 267(2):267-74. PubMed ID: 11426945
[TBL] [Abstract][Full Text] [Related]
14. Gene complementation using myoblast transfer into fetal muscle.
Sopper MM; Hauschka SD; Hoffman E; Ontell M
Gene Ther; 1994 Mar; 1(2):108-13. PubMed ID: 7584065
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo.
Salvatori G; Ferrari G; Mezzogiorno A; Servidei S; Coletta M; Tonali P; Giavazzi R; Cossu G; Mavilio F
Hum Gene Ther; 1993 Dec; 4(6):713-23. PubMed ID: 8186286
[TBL] [Abstract][Full Text] [Related]
16. A self-immunomodulating myoblast cell line for erythropoietin delivery.
Schneider BL; Peduto G; Aebischer P
Gene Ther; 2001 Jan; 8(1):58-66. PubMed ID: 11402302
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases.
Torrente Y; El Fahime E; Caron NJ; Bresolin N; Tremblay JP
Cell Transplant; 2000; 9(4):539-49. PubMed ID: 11038070
[TBL] [Abstract][Full Text] [Related]
18. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.
Vilquin JT; Kinoshita I; Roy B; Goulet M; Engvall E; Tomé F; Fardeau M; Tremblay JP
J Cell Biol; 1996 Apr; 133(1):185-97. PubMed ID: 8601607
[TBL] [Abstract][Full Text] [Related]
19. Differences in the developmental fate of cultured and noncultured myoblasts when transplanted into embryonic limbs.
DiMario JX; Stockdale FE
Exp Cell Res; 1995 Feb; 216(2):431-42. PubMed ID: 7843288
[TBL] [Abstract][Full Text] [Related]
20. Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success.
El Fahime E; Bouchentouf M; Benabdallah BF; Skuk D; Lafreniere JF; Chang YT; Tremblay JP
Biochem Cell Biol; 2003 Apr; 81(2):81-90. PubMed ID: 12870872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
